DiseaseSignal
Genetics & Genomics

Genetics & Genomics

Briefings on gene therapy, genomics, and rare-disease genetics — each summary tied to the study it came from.

2026-07-18 · 2 sources CRISPR that switches a backup gene back on: what the sickle cell editing trial showed

A landmark trial used CRISPR-Cas9 to reactivate fetal hemoglobin in patients' own blood stem cells, freeing a sickle cell and a beta-thalassemia patient from crises and transfusions — and hinting at a pattern reused across blood disorders.